COMP <GO>
ATMU vs DORM // EV/EBITDA & P/E VALUATION
Atmus Filtration Technologies Inc. (NYSE) VS. Dorman Products Inc. (NASDAQ) • 15-METRIC TALLY: ATMU 6
— DORM 5
▲ EV/EBITDA & P/E VALUATION LEADER: ATMU
LAST: $46.46 (+3.04%) • MKT CAP: $3.79B
valuation
11.9x
LAST: $133.67 (+3.03%) • MKT CAP: $3.94B
valuation
12.9x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ATMU VS. DORM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ATMU | DORM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 28.20% | 42.10% | -13.90 | DORM | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 34.60% | 12.90% | +21.70 | ATMU | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 11.9x | 12.9x | -1.00 | ATMU | /valuation <GO> |
| Free Cash Flow Yield | 3.93% | 1.92% | +2.01 | ATMU | /fcf-yield <GO> |
| Operating Margin | 16.90% | 14.10% | +2.80 | ATMU | /operating-margins <GO> |
| Net Profit Margin | 11.80% | 9.60% | +2.20 | ATMU | /net-margins <GO> |
| Revenue Growth (YoY) | 5.70% | 6.00% | -0.30 | DORM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.31 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | DORM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.9 | 69.3 | -14.46 | DORM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 17.0x | 17.9x | -0.90 | ATMU | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.79B | $3.94B | -$151.5M | DORM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ATMU REV | DORM REV | ATMU GROSS % | DORM GROSS % | ATMU FCF | DORM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.76B | $2.13B | 28.2% | 42.1% | $148.8M | $75.7M |
| FY 2024 | $1.67B | $2.01B | 27.7% | 40.1% | $56.8M | $191.6M |
| FY 2023 | $1.63B | $1.93B | — | — | $189.0M | $208.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ATMU // BETA —
DORM // BETA —